BLISS GVS ABOVE ALL EMA

2017년 11월 3일

THE STOCK HAS CLOSED SUCCESSFULLY ABOVE ALL MOVING AVERAGES, MAKING AN UPWARD CHANNEL. AT CMP IT IS A BUY FOR TARGET OF 210.

(***Bliss GVS Pharma Ltd's manufacturing facility (Unit-II) situated at Palghar, Maharashtra has successfully completed the re-audit as per EU-GMP guidelines by European authorities. This inspection was completed without any deficiencies.)

2017년 11월 20일

노트

TRADE ACTIVE BLISS GVS AT 194

2017년 12월 22일

노트

TARGET ACHIEVED @210